ArticleThe Journal of hospital infection2021
Costs associated with COVID-19 in healthcare personnel in Greece: a cost-of-illness analysis.
Article in The Journal of hospital infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis.Systematic reviews · 2024Pooled it
- Costs of inpatient care and out-of-pocket payments for COVID-19 patients: A systematic review.PloS one · 2023Pooled it
- Economic costs related to coronavirus disease 2019 pandemic: A systematic literature review.Science progressPooled it
- Economic burden of COVID-19 on hospitalized patients: a cross-sectional study from Semnan, Iran.BMC health services research · 2026Article
- Economic Burden of COVID-19 Hospitalization in Almaty, Kazakhstan.ClinicoEconomics and outcomes research : CEOR · 2026Article
- The economic burden of COVID-19 premature mortality in Kuwait.BMC public health · 2025Article
- Opportunities Offered by Telemedicine in the Care of Patients Affected by Fractures and Critical Issues: A Narrative Review.Journal of clinical medicine · 2025Review
- Extended Analysis of the Hospitalization Cost and Economic Burden of COVID-19 in Romania.Healthcare (Basel, Switzerland) · 2025Article
- Living With School-Aged Children and the Risk of Absenteeism Among Healthcare Workers During the Twindemic of COVID-19 and Influenza.Influenza and other respiratory viruses · 2025Article
- Article
- Factors influencing healthcare worker symptomatic respiratory infection and vaccine uptake during the post-COVID-19 pandemic period.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025Article
- Health Care Personnel Workdays Lost and Direct Health Care Salary Costs Incurred due to COVID-19 Infection in the Age of Widespread Vaccine Availability.The Journal of infectious diseases · 2024Article
- Cost of illness studies in COVID-19: a scoping review.Cost effectiveness and resource allocation : C/E · 2024Article
- Post-COVID-19 syndrome: persistent symptoms, functional impact, quality of life, return to work, and indirect costs - a prospective case study 12 months after COVID-19 infection.Cadernos de saude publica · 2024Article
- Influenza immunization of healthcare personnel in the post-COVID-19 pandemic era: Still a lot to do!Vaccine: X · 2023Article
- Article
- Absenteeism of Healthcare Personnel in the COVID-19 Era: A Systematic Review of the Literature and Implications for the Post-Pandemic Seasons.Healthcare (Basel, Switzerland) · 2023Review
- Absenteeism Costs Due to COVID-19 and Their Predictors in Non-Hospitalized Patients in Sweden: A Poisson Regression Analysis.International journal of environmental research and public health · 2023Article
- Modelling the economic burden of SARS-CoV-2 infection in health care workers in four countries.Nature communications · 2023Article
- The impacts of the COVID-19 pandemic on indirect costs of mental illness and behavioral disorders in Poland.Frontiers in public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHealthcare personnel (HCP) are at increased risk of infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the aetiological agent of coronavirus disease 2019 (COVID-19).
aimTo estimate the costs related to SARS-CoV-2 exposure and infection among HCP in Greece.
methodsData were retrieved from the national database of SARS-CoV-2 infections and from the database of HCP exposed to patients with COVID-19. A cost-of-illness analysis was performed to estimate total, direct and indirect costs.
resultsIn total, 254 HCP with COVID-19 and 3332 HCP exposed to patients with COVID-19 during the first epidemic wave were studied. Of the 254 HCP with COVID-19, 49 (19.3%) were hospitalized (mean length of hospitalization 11.6 days) and four were admitted to intensive care units (mean duration 10.8 days). Overall, 1332 (40%) exposed HCP had a mean duration of absenteeism of 7.5 days, and 252 (99.2%) HCP with COVID-19 had a mean duration of absenteeism of 25.8 days. The total costs for the management of the two groups were estimated at €1,735,830 (€772,890 Euros for HCP with COVID-19 and €962,940 for exposed HCP). Absenteeism accounted for a large proportion of the total costs (80.4% of all expenditures), followed by costs for reverse transcriptase polymerase chain reaction and hospitalization (10.2% and 6.5% of all expenditures, respectively).
conclusionCOVID-19 is associated with increased rates and duration of absenteeism among HCP. Indirect costs, particularly absenteeism, are the major driver of total costs among exposed HCP and HCP with COVID-19. The estimated total costs are conservative. Studies are needed to explore the impact of COVID-19 vaccination of HCP on absenteeism and COVID-19-associated costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.